Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
Conditions
Fallopian Tube Cancer | Ovarian Cancer | Primary Peritoneal Cavity Cancer
What is the purpose of this trial?
RATIONALE: Learning about the side effects of chemotherapy in older patients may help doctors plan better ways to treat cancer.
PURPOSE: This trial studies the chemotherapy toxicity on quality of life in older patients with stage I, stage II, stage III, or stage IV ovarian epithelial, primary peritoneal cavity, or fallopian tube cancer.
Participation Guidelines
- Age:
- 70 Years and older
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- Gynecologic Oncology Group
- Dates:
- September 2011
- Last Updated:
- April 12, 2012
- Study HIC#:
- 1202009650
Clinicaltrials.gov ID: NCT01366183
For more information about this trial, contact:
Investigator
Thomas Rutherford, MD, PhD
Principal Investigator
